Company News: Amgen (MGN) quarterly earnings beat analysts’ forecast

Market news

3 February 2021

Company News: Amgen (MGN) quarterly earnings beat analysts’ forecast

Amgen (MGN) reported Q4 FY 2020 earnings of $3.81 per share (versus $3.64 per share in Q4 FY 2019), beating analysts’ consensus estimate of $3.34 per share.

The company’s quarterly revenues amounted to $6.634 bln (+7.1% y/y), roughly in line with analysts’ consensus estimate of $6.570 bln.

AMGN fell to $235.00 (-2.28%) in pre-market trading.

U.S. weekly mortgage applications surge 8.1 percent

China's Premier Li: Global economy faces many uncertainties and destabilising factors as “daunting challenges” brought by COVID-19 pandemic remain - Reuters

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.